“…To determine if BMMØs from cathepsin-deficient mice are capable of presenting murine MOG antigens to 2D2 CD4+ T cells, BMMØs derived from WT and cathepsin B, S, L, B/S, or S/L deficient mice were exposed to the immunodominant I-Ab epitope murine MOG 35-55 (0, 1, 10, 25 μg/ml; 0.39–9.7 nM), or to the full extracellular domain of murine MOG (MOG 1-125 ; 0, 1, 10, 25 μg/ml; 0.039–0.96 nM) [31, 34, 37, 38], for 6 h within culture medium. Cultures without BMMØs or MOG, or with concanavalin A (ConA, 5 μg/ml) treatment, were included as negative and positive controls for specific presentation and T cell proliferation respectively.…”